nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
|
Bouter, Yvonne |
|
2015 |
130 |
5 |
p. 713-729 |
artikel |
2 |
Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
|
Bouter, Yvonne |
|
|
130 |
5 |
p. 713-729 |
artikel |
3 |
Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
|
Fuller, James P. |
|
2015 |
130 |
5 |
p. 699-711 |
artikel |
4 |
Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43
|
Walker, Adam K. |
|
2015 |
130 |
5 |
p. 643-660 |
artikel |
5 |
PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk
|
Stamatovic, Svetlana M. |
|
2015 |
130 |
5 |
p. 731-750 |
artikel |
6 |
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia
|
Radford, Helois |
|
2015 |
130 |
5 |
p. 633-642 |
artikel |
7 |
Rab1-dependent ER–Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS
|
Soo, Kai Y. |
|
2015 |
130 |
5 |
p. 679-697 |
artikel |
8 |
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
|
Wagner, Jens |
|
2015 |
130 |
5 |
p. 619-631 |
artikel |
9 |
Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury
|
Chen, Peiwen |
|
2015 |
130 |
5 |
p. 605-618 |
artikel |
10 |
Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS
|
Ke, Yazi D. |
|
2015 |
130 |
5 |
p. 661-678 |
artikel |